We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

New Method Offers Less Invasive Detection of Susceptibility to Rare Anesthesia Reaction

By HospiMedica International staff writers
Posted on 27 Feb 2026

Malignant hyperthermia (MH) is a rare, inherited reaction to general anesthetics that can be rapidly fatal without prompt recognition and treatment. More...

Definitive preoperative testing today relies on an open muscle biopsy, which limits access and creates significant recovery needs. These barriers complicate risk assessment for patients with a family history of the condition. To help address this challenge, researchers now report a less invasive diagnostic approach designed to identify susceptibility before surgery.

Developed at The University of Queensland (Brisbane, Australia), the Calcium Wave Frequency Assay is a diagnostic test intended to detect susceptibility to malignant hyperthermia from a very small muscle sample. The approach uses approximately 1,000-fold less tissue than the current standard, analyzing a single muscle fiber rather than a large open-biopsy specimen. The investigators indicate the method is designed to reduce procedure burden while maintaining the goal of accurate risk stratification before exposure to triggering anesthetics.

Current practice for accurate assessment requires an open biopsy that leaves a 10-centimeter incision on the thigh. The procedure is invasive, costly, and time-consuming, and it cannot be performed in children. Adults may also avoid testing because of anticipated pain, scarring, and days of recovery, limiting identification of at-risk individuals.

Although a blood test for known genetic variants is available, its clinical utility is constrained by a relatively high risk of false-negative results, given the wide range of mutations that can confer susceptibility. During an acute episode, patients may develop severe muscle rigidity, life-threatening hyperthermia, tachycardia, and metabolic acidosis. While a muscle relaxant can be administered to manage the reaction, survivors may still sustain permanent neurological injury. Together, these limitations highlight the need for more reliable and earlier screening approaches.

The research is published in Anaesthesiology and was conducted in collaboration with anesthetists at The Royal Melbourne Hospital and The Children's Hospital at Westmead. The team reports that the next step is full clinical validation of the new assay.

“While MH is a rare condition, anaesthetists need to know if a patient is susceptible so they can take extra precautions, otherwise the person could die during an operation. A muscle relaxant drug can be administered to someone having an MH reaction, but even if the person survives, they can still have permanent neurological damage. It is vital people know this information,” said Professor Bradley Launikonis, School of Biomedical Sciences, The University of Queensland.

“We hope the new test can eventually be done with a minimally invasive needle biopsy and that it could ultimately have implications for other muscle conditions such as Muscular dystrophy,” added Professor Launikonis.

Related Links
University of Queensland


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.